Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026)
Beam Therapeutics' (BEAM) quarterly Prepaid Assets came in at $55.3 million in Q1 2026, up 99.92% year-on-year from $27.7 million in Q1 2025, and up 135.54% on a QoQ basis from $23.5 million in Q4 2025.
Beam Therapeutics (BEAM) Prepaid Assets (2019 - 2026) Analysis & Trends
Beam Therapeutics (BEAM) has 8 years of Prepaid Assets data on file, last reported at $55.3 million in Q1 2026.
- On a quarterly basis, Prepaid Assets rose 99.92% year-over-year to $55.3 million in Q1 2026; TTM through Mar 2026 was $55.3 million, a 99.92% increase from a year earlier, with the FY2025 full-year figure at $23.5 million, down 14.34% from the prior year.
- Prepaid Assets for Q1 2026 stood at $55.3 million, up from $23.5 million in the prior quarter.
- Over the last five years, Prepaid Assets for BEAM reached as high as $55.3 million in Q1 2026 and fell as low as $13.8 million in Q2 2022.
- Historically, Prepaid Assets has averaged $23.6 million across 5 years, with a median of $23.5 million in 2025.
- Across the five-year window, Prepaid Assets surged 100.57% in 2022 and slipped 17.88% in 2024, its largest moves.
- Year by year, Prepaid Assets stood at $14.8 million in 2022, then soared by 43.39% to $21.2 million in 2023, then rose by 29.49% to $27.4 million in 2024, then slipped by 14.34% to $23.5 million in 2025, then jumped by 135.54% to $55.3 million in 2026.
- Per Business Quant data, the three most recent Prepaid Assets figures were $55.3 million in Q1 2026, $23.5 million in Q4 2025, and $23.6 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Beam Therapeutics | 2.61 Bn | 2.61 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 55.30 Mn |
| Dec 31, 2025 | 23.48 Mn |
| Sep 30, 2025 | 23.58 Mn |
| Jun 30, 2025 | 25.13 Mn |
| Mar 31, 2025 | 27.66 Mn |
| Dec 31, 2024 | 27.41 Mn |
| Sep 30, 2024 | 19.78 Mn |
| Jun 30, 2024 | 21.28 Mn |
| Mar 31, 2024 | 27.16 Mn |
| Dec 31, 2023 | 21.17 Mn |
| Sep 30, 2023 | 24.08 Mn |
| Jun 30, 2023 | 21.79 Mn |
| Mar 31, 2023 | 23.56 Mn |
| Dec 31, 2022 | 14.76 Mn |
| Sep 30, 2022 | 14.36 Mn |
| Jun 30, 2022 | 13.78 Mn |
| Mar 31, 2022 | 16.88 Mn |
| Dec 31, 2021 | 7.36 Mn |
| Sep 30, 2021 | 8.02 Mn |
| Jun 30, 2021 | 12.71 Mn |